Royce & Associates LP Harrow Health, Inc. Transaction History
Royce & Associates LP
- $10.3 Billion
- Q4 2024
A detailed history of Royce & Associates LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 292,090 shares of HROW stock, worth $7.12 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
292,090
Previous 360,320
18.94%
Holding current value
$7.12 Million
Previous $16.2 Million
39.51%
% of portfolio
0.1%
Previous 0.15%
Shares
7 transactions
Others Institutions Holding HROW
# of Institutions
185Shares Held
21.1MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$97.3 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$52.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$45.6 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$41.3 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$22.1 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $660M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...